期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

心肌淀粉样变性的MRI诊断 被引量：1

原文传递
导出
摘要 MRI作为一种无创性影像学检查，因其具有软组织分辨率高、多层面、多参数及多序列成像、可重复性好等优势，
作者 喻思思 龚良庚
机构地区 南昌大学第二附属医院放射科
出处 《临床放射学杂志》 CSCD 北大核心 2013年第12期1821-1823,共3页 Journal of Clinical Radiology
基金 江西省科技支撑计划重点资助项目(编号:20121BBG70040)
关键词 MRI诊断 心肌淀粉样变性 无创性影像学检查 多序列成像 可重复性 分辨率 软组织 多层面
分类号 R445.2 [医药卫生—影像医学与核医学]
  • 相关文献

参考文献19

  • 1Banypersad SM, Moon JC, Whelan C, et al. Updates in cardiac amy?loidosis: a review. J Am Heart Assoc ,2012,1.
  • 2万俊义,赵世华,蒋世良,张岩,闫朝武,陆敏杰,周阳,黄洁,赵红.心肌淀粉样变性的临床表现及MRI特征[J].中华放射学杂志,2010,44(12):1297-1299. 被引量：10
  • 3程中伟,方全.心肌淀粉样变的无创诊断方法与临床分型研究进展[J].中华心血管病杂志,2011,39(2):185-187. 被引量：10
  • 4Seeger A, Klumpp B, Kramer U, et al. MRI assessment of cardiac amyloidosis: experience of six cases with review of the current litera?ture. Br J Radiol, 2009 ,82 : 337.
  • 5Vanden Driesen RI, Slaughter RE , Strugnell WE. MR findings in car?diac amyloidosis. AJR,2006, 186: 1682.
  • 6Krombach GA, Hahn C, Tomars M, et al. Cardiac amyloidosis: MR imaging findings and T I quantification, comparison with control sub?jects. J Magn Reson Imaging,2007 ,25: 1283.
  • 7Hosch W, Bock M, Libicher M, et al. MR-relaxometry of myocardial tissue: significant elevation of T I and T 2 relaxation times in cardiac amyloidosis. Invest Radiol ,2007,42 :636.
  • 8Perugini E, Rapezzi C, Piva T, et al. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart,2006 ,92 :343.
  • 9Sparrow P , Amirabadi A, Sussman MS, et al. Quantitative assessment of myocardial T2 relaxation times in cardiac amyloidosis. J Magn Re?son Imaging ,2009,30 :942.
  • 10Wassmuth R, Abdel-Aty H, Bohl S, et al. Prognostic impact of T2- weighted CMR imaging for cardiac amyloidosis. Eur Radiol, 2011, 21: 1643.

二级参考文献64

  • 1Maron BJ,Towbin JA,Thiene G,et al.Contemporary definitions and classification of the cardiomyopathies:an American Heart Association Scientific Statement from the council on clinical cardiology,heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention[J].Circulation,2006,113:1807-1816.
  • 2Moon JC,Reed E,Sheppard MN,et al.The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy[J]J Am Coll Cardiol,2004,43:2260-2264.
  • 3Hunold P,Wieneke H,Bruder O,et al.Late enhancement:a new feature in MRI of arrhythmogenic right ventricular cardiomyopathy?[J].J Cardiovasc Magn Reson,2005,7:649-655.
  • 4White JA,Patel MR.The role of cardiovascular MRI in heart failure and the cardiomyopathies[J].Cardid Clin,2007,25:71-95,Vi.
  • 5Tandri H,Saranathan M,Rodriguez ER,et al.Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging[J].J Am Coll Cardiol,2005,45:98-103.
  • 6Turrini P,Angelini A,Thiene G,et al.Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy[J].Am J Cardiol,1999,83:1214-1219.
  • 7Dodd JD,Holmvang G,Hoffmann U,et al.Quantification of left ventricular noncompaction and trabecular delayed hyperenhancement with cardiac MRI:correlation with clinical severity[J].AJR,2007,189:974-980.
  • 8Petersen SE,Selvanayagam JB,Wiesmann F,et al.Left ventricular non-compaction:insights from cardiovascular magnetic resonance imaging[J].J Am Coll Cardiol,2005,46:101-105.
  • 9Masci PG,Dymarkowski S,Bogaert J.The role of cardiovascular magnetic resonance in the diagnosis and management of cardiomyopathies[J].J Cardiovasc Med (Hagerstown),2008,9:435-449.
  • 10Nazarian S,Bluemke DA,Lardo AC,et al.Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy[J].Circulation,2005,112:2821-2825.

共引文献22

同被引文献2

引证文献1

临床放射学杂志
2013年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部